VANCOUVER, BC – The first patient has entered the Phase II/III trial of ST-02, Sustained Therapeutic’s innovative cancer medication targeting Upper Tract Urethral Carcinoma (UTUC). A rare form of cancer,… Read More
TORONTO, ON – The Ontario Ministry of Health has announced a universal public program with Beyfortus® (nirsevimab) for all newborns and infants born in 2024 and through the 2024-2025 RSV… Read More
VeroSource, a subsidiary of HEALWELL, built the new Patient Summary feature that launched on the MyHealthNB mobile app in partnership with Canada Health Infoway and the Government of New Brunswick…. Read More
BIOTECanada welcomes the announcement that the Government of Canada has entered into a bilateral agreement with the province of British Columbia which will improve access to drugs for rare diseases,… Read More
VANCOUVER, BC – WEX Pharmaceuticals Inc. (“WEX” or the “Company”), a biotechnology company developing Halneuron® (Tetrodotoxin for Injection) for pain treatment, announced that it has filed a patent application for… Read More
